(
A–E) Transgenic co-receptor
Gal4 lines crossed to a strong
UAS reporter reveal expression in some, but not all, of the additional glomeruli labeled by the respective knock-ins. Some discrepancies between the
Gal4 and knock-in lines are enumerated here, but do not represent a comprehensive list. (
A)
Orco-Gal4 drives weak GFP expression in VL2a and VM4 glomeruli (outlined), but lacks expression in DL2, V, and VL1 glomeruli, which are labeled by the knock-in. (
B)
Ir8a-Gal4>GFP labels VC3 and VL1 (outlined), but lacks expression in the VM4 and VA3 glomeruli, which are labeled in the knock-in. (
C)
Ir76b-Gal4 labels the VL1 and VL2a glomeruli (outlined), but lacks expression in the VA5 and DC3 glomeruli that are consistently labeled in the knock-in. Additionally, it drives GFP expression in Orco+ glomeruli not seen in the knock-in (outlined). (
D)
Ir25a-Gal4 labels some Orco+ glomeruli (outline includes DA2, DA3, DA4m, and DA4l), but is lacking expression in many glomeruli labeled by the knock-in. (
E) The
UAS-GFP control line has weak leaky expression in the subesophageal zone (SEZ) but no expression in the antennal lobe (AL). (
A) shows single slice to visualize weakly labeled glomeruli; (
B–E) are maximum intensity projections of z-stacks. Scale bar = 50 µm. See also
Figure 3—source data 1.